Table 4.
Group comparison for TN, TA, and BMA at 2- and 4-weeks.
| Variable | Duration | Groups | Comparison | |
|---|---|---|---|---|
| Mean differences | P Value | |||
| TN | 2-weeks | C/GS | −3.200 | 0.01∗ |
| C/[GS/PSO] | −5.400 | 0.003∗ | ||
| GS/[GS/PSO] | −2.200 | 0.030∗ | ||
| 4-weeks | C/GS | 0.290 | 0.825 | |
| C/[GS/PSO] | 0.490 | 0.379 | ||
| GS/[GS/PSO] | 0.120 | 0.508 | ||
|
| ||||
| TA | 2-weeks | C/GS | −0.036 | 0.009∗ |
| C/[GS/PSO] | −0.104 | 0.02∗ | ||
| GS/[GS/PSO] | −0.068 | 0.080 | ||
| 4-weeks | C/GS | −0.435 | 0.009∗ | |
| C/[GS/PSO] | −0.189 | 0.0001∗∗ | ||
| GS/[GS/PSO] | −0.554 | 0.007∗ | ||
|
| ||||
| BMA | 2-weeks | C/GS | 0.092 | 0.002∗ |
| C/[GS/PSO] | 0.175 | 0.0001∗∗ | ||
| GS/[GS/PSO] | 0.087 | 0.002∗ | ||
| 4-weeks | C/GS | 0.043 | 0.0001∗∗ | |
| C/[GS/PSO] | 0.100 | 0.0001∗∗ | ||
| GS/[GS/PSO] | 0.057 | 0.0001∗∗ | ||
∗ significant (P > 0.05), ∗∗high significant (P ≤ 0.001).